GPT and congestive heart failure: Pregnant or lactating females, those with ECOG performance status > 2, impaired LV systolic function in which LVEF < 50%, documented coronary artery disease, significant valvular heart disease, history of cardiomyopathy or congestive heart failure (CHF), ALT > 3 times ULN, Patients already taking statins or any other lipid lowering drug or with a known hypersensitivity to any of the used drugs were excluded from the study.